hamburger-icon
close-icon

invest-iconInvest

trade-iconTrade

depository-iconInsurance

watch-iconPMS

depository-iconTrading Platforms

depository-iconDepository

watch-iconWatch Markets

depository-iconFPI

watch-iconMerchant Banking

watch-iconInstitutional Broking

watch-iconMTF

partner-iconBecome a Partner

partner-iconKnowledge Center

watch-iconResearch

about-iconAbout Us

support-iconSupport

support-iconPricing

support-iconQuick Links

support-iconBlog

hamburger-icon
close-icon

Cipla Ltd

  • BSE Code : 500087
  • NSE Symbol : CIPLA
  • ISIN : INE059A01026
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN
Trade Now

up-arrow 1,404.05 5.00(0.36%)

Open Price (₹)

1,403.90

Prev. Close (₹)

1,399.05

Volume (No’s)

60,540

Market Cap (₹)

113,362.29

Low Price (₹)

1,400.25

High Price (₹)

1,407.30

 

Board Meetings

Start Date End Date Purpose
05-Apr-2024 10-May-2024 CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 inter alia to consider and approve 1. Consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended 31st March 2024. 2. Recommend final dividend for the year ended 31st March 2024 if any. In terms of the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in the securities of the Company is closed from Monday 1st April 2024 till Sunday 12th May 2024 (both days inclusive) for the purpose of financial results. Outcome of board meeting held on 10th May 2024 Appointment of Cost Auditor for FY 2024-25 (As Per BSE Announcement Dated on 10/05/2024)
03-Jan-2024 22-Jan-2024 CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2024 inter alia to consider and approve Pursuant to regulation 29 of listing regulations we wish to inform you that the meeting of the board of directors of the company will he held on Thursday 25th January 2024 interalia to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended 31st december 2023. The Board Meeting to be held on 25/01/2024 has been revised to 22/01/2024 The Board Meeting to be held on 25/01/2024 has been revised to 22/01/2024 (As per BSE Announcement Dated on 20/01/2024) The Board of Directors of the company at its meeting held on 22nd Jan 2024, has approved unaudited consolidated and standalone financial results. (As Per BSE Announcement dated on 22.01.2024)
06-Nov-2023 06-Nov-2023 Intimation pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 regarding Slump Sale of Business Undertaking is enclosed.
04-Oct-2023 27-Oct-2023 CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 inter alia to consider and approve Pursuant to Regulation 29 of Listing Regulations we wish to inform you that a meeting of the Board of Directors of the Company will be held on Friday 27th October 2023 inter-alia to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2023. In terms of the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in the securities of the Company is closed from Sunday 1st October 2023 till Sunday 29th October 2023 (both days inclusive) for the purpose of financial results. The Board of Directors of the company at its meeting held on 27th October 2023, has approved unaudited consolidated and standalone financial result. Please find the attached extract of the consolidated unaudited financial results for the quarter ended 30th September 2023 to be published in newspaper. (As Per BSE Announcement dated on 27.10.2023)
04-Jul-2023 26-Jul-2023 CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2023 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30th June 2023. CIPLA LIMITED has informed BSE about Board Meeting to be held on 26 Jul 2023 to consider financial statements for the period ended June 2023. Financial results / Other business. The Board of Directors of the Company at its meeting held on today i.e. 26th July, 2023, has approved unaudited consolidated and standalone financial result. Please find the attached outcome of Board meeting held today i.e. 26th July, 2023. (As Per BSE Announcement dated on 26.07.2023) We wish to inform that, Board of directors of the Company at its meeting held on 26th July, 2023 has approved the changes in the Key Managerial Personnel (KMPs) authorised under Regulation 30(5) of the Listing Regulations with effect from 26th July 2023. The Contact details of the KMPs authourised under Regulation 30(5) of the listing regulations are enclosed. (As Per BSE Announcement Dated on 27.07.2023)

NIFTY:22,502.00  Up arrow
35.90(0.16%)
SENSEX:73,917.03  Up arrow
88.91(0.12%)

Product

Trading


Useful links

Who we are

Connect with us

Stay on top of the markets with our bite-sized newsletter delivered right to your Inbox!

footer-arrow-icon
appstore appstore

#1011 Solitaire Corporate Park, Andheri Ghatkopar Link Road, Chakala, Andheri (E), Mumbai - 400093.

Arihant Capital Markets Limited is a SEBI registered stock broker and depository participant. SEBI Registration number for NSE & BSE :- INZ000180939; NSDL - IN-DP-127-2015 DP ID-IN301983; CDSL DP ID-43000;NCDEX - 01274; MCX - 56565; AMFI - ARN 15114; SEBI Merchant Banking Reg. No. - MB INM000011070; SEBI Research Analyst Reg. No. - INH000002764. Registered Address: 6, Lad colony, Y.N. Road, Indore – 452001.Corporate office address: #1011 Solitaire Corporate Park, Andheri Ghatkopar Link Road, Chakala, Andheri (E), Mumbai - 400093.

Please carefully read the risk disclosure document as prescribed by SEBI, as well as the 'Do’s and Don’ts' provided by NSE, BSE, NCDEX, and MCX. If you have any complaints related to securities broking, kindly contact us at complaint@arihantcapital.com. For DP-related matters, please reach out to us at depository@arihantcapital.com.

If you want to register your complaints through SEBI Score Portal please click here. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances

Investments in securities market are subject to market risks; read all the related documents carefully before investing.

Disclaimer: Arihant Capital Markets Limited is engaged in client based and proprietary trading on various exchanges.

  • ATTENTION INVESTORS :
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • For Stock Broking Transaction 'Prevent unauthorised transactions in your account - update your mobile numbers/email IDs with your stockbrokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.
  • For Depository Transaction 'Prevent Unauthorized Transactions in your demat account - Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL/NSDL on the same day.
  • If you are subscribing to an IPO, there is no need to issue cheques. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website.
  • Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Awareness regarding guidelines of margin collection:
1)Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
2)Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
3)Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.
Issued in the interest of investors

Dear Investor - As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor. https://www.bseipf.com/investors_education.html

Copyright © 2019 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)